Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 27 | 2024 | 3431 | 3.050 |
Why?
|
Vaccines | 15 | 2024 | 842 | 2.690 |
Why?
|
Pneumococcal Infections | 6 | 2022 | 529 | 2.420 |
Why?
|
Immunization Programs | 11 | 2022 | 267 | 2.360 |
Why?
|
Pneumococcal Vaccines | 6 | 2022 | 414 | 2.120 |
Why?
|
Meningococcal Infections | 4 | 2024 | 78 | 1.890 |
Why?
|
Meningococcal Vaccines | 3 | 2024 | 96 | 1.690 |
Why?
|
Cost-Benefit Analysis | 27 | 2024 | 5538 | 1.620 |
Why?
|
Cost of Illness | 8 | 2024 | 1959 | 1.590 |
Why?
|
Economics | 8 | 2014 | 141 | 1.380 |
Why?
|
Quality-Adjusted Life Years | 4 | 2024 | 1735 | 1.200 |
Why?
|
Models, Economic | 5 | 2024 | 718 | 1.190 |
Why?
|
Public Health | 11 | 2021 | 2682 | 1.100 |
Why?
|
Commerce | 6 | 2019 | 612 | 1.060 |
Why?
|
Gross Domestic Product | 7 | 2024 | 77 | 1.060 |
Why?
|
Health Policy | 16 | 2022 | 2698 | 1.050 |
Why?
|
Population Dynamics | 8 | 2014 | 314 | 1.040 |
Why?
|
India | 26 | 2024 | 2325 | 1.000 |
Why?
|
Streptococcus pneumoniae | 3 | 2020 | 764 | 0.960 |
Why?
|
Developed Countries | 9 | 2019 | 452 | 0.830 |
Why?
|
Visually Impaired Persons | 1 | 2022 | 79 | 0.780 |
Why?
|
Delivery of Health Care | 10 | 2021 | 5375 | 0.750 |
Why?
|
Economic Development | 5 | 2020 | 72 | 0.740 |
Why?
|
Poverty Areas | 5 | 2015 | 269 | 0.730 |
Why?
|
Public-Private Sector Partnerships | 2 | 2021 | 123 | 0.720 |
Why?
|
Drug Resistance, Microbial | 4 | 2024 | 830 | 0.720 |
Why?
|
Vision, Low | 1 | 2022 | 162 | 0.720 |
Why?
|
Socioeconomic Factors | 13 | 2023 | 7861 | 0.710 |
Why?
|
Developing Countries | 14 | 2023 | 2903 | 0.700 |
Why?
|
Income | 5 | 2023 | 1877 | 0.690 |
Why?
|
Markov Chains | 1 | 2024 | 977 | 0.690 |
Why?
|
Dementia | 6 | 2024 | 2729 | 0.680 |
Why?
|
Health Status | 6 | 2023 | 4094 | 0.680 |
Why?
|
Carbamates | 1 | 2021 | 192 | 0.680 |
Why?
|
Acquired Immunodeficiency Syndrome | 10 | 2016 | 2202 | 0.660 |
Why?
|
Women's Health | 3 | 2020 | 2078 | 0.630 |
Why?
|
Hypothermia | 2 | 2017 | 188 | 0.610 |
Why?
|
Life Expectancy | 7 | 2014 | 1249 | 0.610 |
Why?
|
Infant Equipment | 1 | 2017 | 23 | 0.600 |
Why?
|
Technology Assessment, Biomedical | 1 | 2020 | 309 | 0.580 |
Why?
|
Achievement | 2 | 2018 | 288 | 0.580 |
Why?
|
Water Supply | 2 | 2015 | 204 | 0.550 |
Why?
|
Population Density | 3 | 2014 | 193 | 0.540 |
Why?
|
Health Services Needs and Demand | 5 | 2021 | 1407 | 0.530 |
Why?
|
Infant Care | 1 | 2017 | 182 | 0.530 |
Why?
|
Humans | 148 | 2025 | 768393 | 0.530 |
Why?
|
Dengue | 2 | 2017 | 258 | 0.530 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 148 | 0.500 |
Why?
|
Health Services for the Aged | 2 | 2014 | 258 | 0.490 |
Why?
|
Vaccines, Conjugate | 3 | 2022 | 334 | 0.480 |
Why?
|
Longitudinal Studies | 14 | 2025 | 14784 | 0.470 |
Why?
|
Population Growth | 3 | 2011 | 50 | 0.470 |
Why?
|
Private Sector | 1 | 2017 | 396 | 0.470 |
Why?
|
Social Behavior | 1 | 2021 | 1146 | 0.460 |
Why?
|
Hepatitis C | 2 | 2022 | 1593 | 0.460 |
Why?
|
Accidents, Traffic | 1 | 2019 | 819 | 0.440 |
Why?
|
Mass Vaccination | 2 | 2014 | 110 | 0.430 |
Why?
|
Pandemics | 10 | 2024 | 8753 | 0.410 |
Why?
|
Mortality | 5 | 2021 | 2917 | 0.400 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2046 | 0.400 |
Why?
|
Communicable Diseases | 3 | 2019 | 873 | 0.390 |
Why?
|
Health Care Rationing | 1 | 2015 | 435 | 0.390 |
Why?
|
Aging | 11 | 2024 | 8764 | 0.380 |
Why?
|
Needs Assessment | 5 | 2013 | 1142 | 0.380 |
Why?
|
World Health Organization | 7 | 2019 | 1327 | 0.370 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2022 | 1568 | 0.370 |
Why?
|
Health Expenditures | 4 | 2021 | 2395 | 0.360 |
Why?
|
Demography | 8 | 2013 | 1642 | 0.360 |
Why?
|
Communicable Disease Control | 5 | 2024 | 857 | 0.360 |
Why?
|
United Nations | 3 | 2021 | 151 | 0.350 |
Why?
|
Neisseria meningitidis, Serogroup B | 2 | 2020 | 6 | 0.350 |
Why?
|
Mental Health | 5 | 2025 | 3276 | 0.350 |
Why?
|
Child Mortality | 2 | 2016 | 204 | 0.340 |
Why?
|
Antiviral Agents | 2 | 2022 | 3064 | 0.330 |
Why?
|
Infant Mortality | 2 | 2013 | 757 | 0.330 |
Why?
|
Anti-HIV Agents | 7 | 2016 | 4571 | 0.330 |
Why?
|
Interinstitutional Relations | 2 | 2000 | 236 | 0.320 |
Why?
|
Convalescence | 1 | 2009 | 109 | 0.320 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2034 | 0.320 |
Why?
|
Biomedical Research | 2 | 2024 | 3464 | 0.320 |
Why?
|
Mental Disorders | 2 | 2023 | 6876 | 0.300 |
Why?
|
Research | 9 | 2023 | 1981 | 0.300 |
Why?
|
Physician Incentive Plans | 1 | 2009 | 165 | 0.290 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2016 | 1903 | 0.290 |
Why?
|
HIV Infections | 15 | 2016 | 17575 | 0.290 |
Why?
|
Immunization Schedule | 2 | 2019 | 228 | 0.280 |
Why?
|
Drug Discovery | 1 | 2015 | 1067 | 0.280 |
Why?
|
China | 4 | 2023 | 2395 | 0.280 |
Why?
|
Social Class | 4 | 2015 | 2009 | 0.280 |
Why?
|
Medically Underserved Area | 1 | 2009 | 266 | 0.280 |
Why?
|
Rheumatic Heart Disease | 2 | 2020 | 164 | 0.270 |
Why?
|
Haemophilus influenzae type b | 2 | 2019 | 16 | 0.260 |
Why?
|
Bacterial Vaccines | 2 | 2018 | 400 | 0.260 |
Why?
|
Prevalence | 12 | 2024 | 15872 | 0.260 |
Why?
|
Fertility | 6 | 2016 | 772 | 0.250 |
Why?
|
Haemophilus Vaccines | 2 | 2019 | 71 | 0.250 |
Why?
|
Rural Health Services | 1 | 2009 | 393 | 0.250 |
Why?
|
Air Pollution | 1 | 2019 | 2363 | 0.240 |
Why?
|
Conservation of Natural Resources | 1 | 2007 | 209 | 0.240 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3413 | 0.240 |
Why?
|
Child | 23 | 2025 | 80891 | 0.240 |
Why?
|
Influenza Vaccines | 2 | 2022 | 780 | 0.240 |
Why?
|
Aged | 26 | 2024 | 171562 | 0.230 |
Why?
|
Female | 52 | 2025 | 397089 | 0.230 |
Why?
|
Efficiency | 3 | 2020 | 477 | 0.220 |
Why?
|
Planets | 1 | 2023 | 7 | 0.220 |
Why?
|
Alzheimer Disease | 2 | 2024 | 8747 | 0.220 |
Why?
|
Health Care Costs | 6 | 2022 | 3267 | 0.210 |
Why?
|
Ontario | 2 | 2018 | 403 | 0.210 |
Why?
|
Models, Theoretical | 10 | 2017 | 3579 | 0.210 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1629 | 0.210 |
Why?
|
Attitude to Health | 3 | 2009 | 2025 | 0.210 |
Why?
|
Male | 43 | 2025 | 364902 | 0.210 |
Why?
|
Virology | 1 | 2023 | 76 | 0.210 |
Why?
|
Marriage | 5 | 1990 | 352 | 0.210 |
Why?
|
Employment | 4 | 1995 | 1116 | 0.200 |
Why?
|
Human Rights | 2 | 2021 | 312 | 0.200 |
Why?
|
Visual Acuity | 2 | 2024 | 2714 | 0.200 |
Why?
|
Homes for the Aged | 1 | 2024 | 273 | 0.200 |
Why?
|
Pharyngitis | 1 | 2023 | 222 | 0.190 |
Why?
|
Urinary Bladder Diseases | 1 | 2022 | 167 | 0.190 |
Why?
|
Salaries and Fringe Benefits | 3 | 1995 | 262 | 0.190 |
Why?
|
Age Factors | 11 | 2021 | 18471 | 0.190 |
Why?
|
Urination Disorders | 1 | 2022 | 238 | 0.190 |
Why?
|
Brazil | 2 | 2023 | 1248 | 0.180 |
Why?
|
Health Status Disparities | 2 | 2015 | 1882 | 0.180 |
Why?
|
Infant | 12 | 2024 | 36510 | 0.180 |
Why?
|
United States | 21 | 2025 | 73150 | 0.180 |
Why?
|
Urbanization | 1 | 2021 | 101 | 0.180 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5891 | 0.180 |
Why?
|
Forecasting | 4 | 2024 | 2948 | 0.180 |
Why?
|
Least-Squares Analysis | 1 | 2021 | 368 | 0.180 |
Why?
|
Substance Abuse, Intravenous | 1 | 2005 | 530 | 0.170 |
Why?
|
Retinoscopy | 1 | 2019 | 27 | 0.170 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1133 | 0.170 |
Why?
|
Organizations | 2 | 2017 | 172 | 0.170 |
Why?
|
Neisseria meningitidis, Serogroup A | 1 | 2019 | 6 | 0.170 |
Why?
|
Family Characteristics | 5 | 2015 | 1003 | 0.170 |
Why?
|
Emigration and Immigration | 2 | 2008 | 406 | 0.160 |
Why?
|
International Normalized Ratio | 1 | 2021 | 382 | 0.160 |
Why?
|
Ebola Vaccines | 1 | 2019 | 25 | 0.160 |
Why?
|
Turkey | 1 | 2020 | 256 | 0.160 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2022 | 475 | 0.160 |
Why?
|
Streptococcal Infections | 1 | 2023 | 619 | 0.160 |
Why?
|
France | 1 | 2020 | 497 | 0.160 |
Why?
|
Veterans Health | 1 | 2021 | 215 | 0.160 |
Why?
|
Hospitalization | 3 | 2020 | 10844 | 0.160 |
Why?
|
Measles Vaccine | 1 | 2019 | 80 | 0.160 |
Why?
|
Adaptation, Psychological | 2 | 2009 | 2663 | 0.160 |
Why?
|
Blindness | 1 | 2022 | 587 | 0.150 |
Why?
|
Virus Diseases | 2 | 2023 | 723 | 0.150 |
Why?
|
Refraction, Ocular | 1 | 2019 | 186 | 0.150 |
Why?
|
Bacterial Capsules | 1 | 2019 | 247 | 0.150 |
Why?
|
Geography | 2 | 2014 | 654 | 0.150 |
Why?
|
Residence Characteristics | 4 | 2015 | 2122 | 0.150 |
Why?
|
Germany | 1 | 2020 | 882 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2022 | 3440 | 0.150 |
Why?
|
Refractive Errors | 1 | 2019 | 148 | 0.150 |
Why?
|
Adolescent | 23 | 2025 | 89184 | 0.150 |
Why?
|
Anthropometry | 2 | 2019 | 1343 | 0.150 |
Why?
|
Ecology | 1 | 1998 | 105 | 0.140 |
Why?
|
Government | 2 | 2019 | 161 | 0.140 |
Why?
|
South Africa | 6 | 2016 | 1871 | 0.140 |
Why?
|
Cardiovascular Diseases | 3 | 2019 | 15649 | 0.140 |
Why?
|
Health Personnel | 2 | 2022 | 3380 | 0.140 |
Why?
|
Investments | 2 | 2016 | 149 | 0.140 |
Why?
|
Climate | 1 | 1998 | 147 | 0.140 |
Why?
|
Seasons | 2 | 2021 | 1526 | 0.140 |
Why?
|
Vision Disorders | 1 | 2024 | 1093 | 0.140 |
Why?
|
Data Collection | 2 | 2014 | 3324 | 0.140 |
Why?
|
Systems Biology | 1 | 2020 | 479 | 0.140 |
Why?
|
Caregivers | 3 | 2024 | 2303 | 0.140 |
Why?
|
Nepal | 1 | 2017 | 301 | 0.140 |
Why?
|
Quality Improvement | 4 | 2021 | 3858 | 0.130 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7463 | 0.130 |
Why?
|
Prejudice | 3 | 2000 | 574 | 0.130 |
Why?
|
Health Care Sector | 1 | 2018 | 197 | 0.130 |
Why?
|
Middle Aged | 24 | 2024 | 223491 | 0.130 |
Why?
|
Infertility, Female | 1 | 2022 | 765 | 0.130 |
Why?
|
Drugs, Generic | 1 | 2021 | 454 | 0.130 |
Why?
|
Denmark | 1 | 2018 | 779 | 0.130 |
Why?
|
Quality of Life | 4 | 2021 | 13503 | 0.130 |
Why?
|
Child, Preschool | 13 | 2022 | 42650 | 0.130 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 871 | 0.130 |
Why?
|
Computers | 1 | 1998 | 592 | 0.130 |
Why?
|
Policy Making | 4 | 2023 | 545 | 0.120 |
Why?
|
Nutritional Requirements | 1 | 2017 | 279 | 0.120 |
Why?
|
Sex Ratio | 2 | 2015 | 107 | 0.120 |
Why?
|
Research Design | 4 | 2022 | 6210 | 0.120 |
Why?
|
Travel | 1 | 2021 | 800 | 0.120 |
Why?
|
Family Planning Services | 2 | 2016 | 279 | 0.120 |
Why?
|
Haplotypes | 1 | 2021 | 2724 | 0.120 |
Why?
|
Disease Outbreaks | 2 | 2007 | 1762 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2022 | 634 | 0.120 |
Why?
|
Adult | 25 | 2023 | 223640 | 0.120 |
Why?
|
Gonorrhea | 1 | 2018 | 355 | 0.120 |
Why?
|
Temperature | 1 | 2021 | 2235 | 0.120 |
Why?
|
Acculturation | 1 | 1995 | 179 | 0.110 |
Why?
|
Interviews as Topic | 2 | 2020 | 2740 | 0.110 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2027 | 0.110 |
Why?
|
Anti-Retroviral Agents | 2 | 2016 | 1794 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2021 | 1838 | 0.110 |
Why?
|
Blood Pressure | 3 | 2022 | 8541 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2022 | 1031 | 0.110 |
Why?
|
Portugal | 1 | 2013 | 91 | 0.110 |
Why?
|
Dengue Vaccines | 1 | 2013 | 16 | 0.110 |
Why?
|
Disabled Persons | 2 | 2021 | 1215 | 0.110 |
Why?
|
Neuropsychological Tests | 3 | 2023 | 7145 | 0.110 |
Why?
|
Poverty | 4 | 2022 | 2721 | 0.110 |
Why?
|
Drug Approval | 1 | 2020 | 818 | 0.110 |
Why?
|
Cognition | 3 | 2020 | 7075 | 0.110 |
Why?
|
Health Status Indicators | 1 | 2018 | 971 | 0.110 |
Why?
|
Maternal Age | 4 | 1986 | 809 | 0.110 |
Why?
|
National Health Programs | 2 | 2014 | 442 | 0.110 |
Why?
|
Americas | 5 | 1995 | 110 | 0.110 |
Why?
|
International Cooperation | 3 | 2014 | 1438 | 0.100 |
Why?
|
Birth Rate | 3 | 2011 | 168 | 0.100 |
Why?
|
Stress, Psychological | 3 | 2025 | 4543 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1422 | 0.100 |
Why?
|
Vesico-Ureteral Reflux | 1 | 1996 | 433 | 0.100 |
Why?
|
Health Behavior | 2 | 2017 | 2647 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59686 | 0.100 |
Why?
|
Water Microbiology | 1 | 2013 | 117 | 0.100 |
Why?
|
Nutrition Policy | 1 | 2016 | 467 | 0.100 |
Why?
|
Quality Control | 1 | 2015 | 833 | 0.100 |
Why?
|
Program Evaluation | 2 | 2012 | 2505 | 0.100 |
Why?
|
Biological Assay | 1 | 2015 | 627 | 0.100 |
Why?
|
Models, Econometric | 2 | 2010 | 215 | 0.100 |
Why?
|
Aortic Valve | 1 | 2022 | 1969 | 0.100 |
Why?
|
Public Policy | 1 | 1995 | 551 | 0.090 |
Why?
|
Circumcision, Male | 1 | 2012 | 148 | 0.090 |
Why?
|
Statistics as Topic | 6 | 1993 | 2363 | 0.090 |
Why?
|
Cohort Studies | 8 | 2024 | 41795 | 0.090 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 1959 | 0.090 |
Why?
|
Haemophilus Infections | 1 | 2010 | 94 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1539 | 0.090 |
Why?
|
Climate Change | 1 | 2017 | 508 | 0.090 |
Why?
|
Long-Term Care | 1 | 2014 | 632 | 0.090 |
Why?
|
Infant, Newborn | 8 | 2021 | 26411 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1063 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2022 | 4047 | 0.080 |
Why?
|
Africa South of the Sahara | 2 | 2012 | 751 | 0.080 |
Why?
|
Financing, Organized | 1 | 2011 | 203 | 0.080 |
Why?
|
Nursing Methodology Research | 1 | 2009 | 64 | 0.080 |
Why?
|
Adolescent Behavior | 1 | 1998 | 1190 | 0.080 |
Why?
|
Quebec | 1 | 2009 | 139 | 0.080 |
Why?
|
Battered Women | 1 | 2009 | 36 | 0.080 |
Why?
|
Young Adult | 7 | 2023 | 60049 | 0.080 |
Why?
|
North America | 5 | 1995 | 1290 | 0.080 |
Why?
|
HIV | 2 | 2016 | 1596 | 0.080 |
Why?
|
Students | 1 | 2019 | 1744 | 0.080 |
Why?
|
Australia | 2 | 2022 | 1265 | 0.080 |
Why?
|
Age Distribution | 2 | 2012 | 2877 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1468 | 0.080 |
Why?
|
Fiji | 2 | 2020 | 47 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3243 | 0.080 |
Why?
|
Risk Factors | 10 | 2022 | 74962 | 0.080 |
Why?
|
Midwestern United States | 1 | 2008 | 70 | 0.070 |
Why?
|
Birth Order | 2 | 1993 | 95 | 0.070 |
Why?
|
Nurse's Role | 1 | 2009 | 188 | 0.070 |
Why?
|
Genome, Human | 1 | 2021 | 4450 | 0.070 |
Why?
|
Sex Factors | 4 | 2015 | 10654 | 0.070 |
Why?
|
Southeastern United States | 1 | 2008 | 93 | 0.070 |
Why?
|
Spouse Abuse | 1 | 2009 | 182 | 0.070 |
Why?
|
Immunity, Herd | 2 | 2020 | 48 | 0.070 |
Why?
|
Educational Status | 4 | 2023 | 2518 | 0.070 |
Why?
|
Population Characteristics | 4 | 1995 | 13 | 0.070 |
Why?
|
Rural Population | 1 | 2017 | 2318 | 0.070 |
Why?
|
Qualitative Research | 3 | 2021 | 3131 | 0.070 |
Why?
|
Immunization | 1 | 2011 | 1219 | 0.070 |
Why?
|
Population | 4 | 1995 | 141 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2025 | 81801 | 0.070 |
Why?
|
Morbidity | 2 | 2023 | 1758 | 0.070 |
Why?
|
Unemployment | 1 | 1988 | 210 | 0.070 |
Why?
|
Urban Population | 1 | 2014 | 2045 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2015 | 3857 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2012 | 497 | 0.060 |
Why?
|
Comorbidity | 1 | 2021 | 10588 | 0.060 |
Why?
|
Vietnam | 2 | 2019 | 416 | 0.060 |
Why?
|
Diet | 2 | 2017 | 8090 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2337 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3231 | 0.060 |
Why?
|
HIV Seropositivity | 1 | 1991 | 962 | 0.060 |
Why?
|
Needle-Exchange Programs | 1 | 2005 | 27 | 0.060 |
Why?
|
Patient Preference | 1 | 2012 | 947 | 0.060 |
Why?
|
Self Care | 1 | 2009 | 797 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 8075 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8615 | 0.050 |
Why?
|
Models, Biological | 3 | 2012 | 9493 | 0.050 |
Why?
|
Monte Carlo Method | 1 | 2008 | 1261 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2009 | 964 | 0.050 |
Why?
|
Body Height | 2 | 2019 | 1568 | 0.050 |
Why?
|
Drug Industry | 2 | 2018 | 793 | 0.050 |
Why?
|
Energy Intake | 1 | 2010 | 2145 | 0.050 |
Why?
|
Body Mass Index | 2 | 2019 | 13052 | 0.050 |
Why?
|
Chronic Disease | 3 | 2017 | 9379 | 0.050 |
Why?
|
Georgia | 1 | 2022 | 186 | 0.050 |
Why?
|
Mammography | 1 | 2012 | 2434 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2010 | 5512 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16028 | 0.050 |
Why?
|
Pregnancy | 5 | 2021 | 30200 | 0.050 |
Why?
|
Africa | 2 | 2007 | 726 | 0.050 |
Why?
|
Streptococcus pyogenes | 1 | 2023 | 293 | 0.050 |
Why?
|
Belgium | 1 | 2020 | 119 | 0.050 |
Why?
|
Marital Status | 2 | 2009 | 426 | 0.050 |
Why?
|
Costs and Cost Analysis | 3 | 2012 | 1669 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 1640 | 0.040 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2012 | 2044 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 65379 | 0.040 |
Why?
|
Meningitis, Haemophilus | 1 | 2019 | 20 | 0.040 |
Why?
|
Financial Support | 1 | 2000 | 116 | 0.040 |
Why?
|
Social Support | 1 | 2009 | 2191 | 0.040 |
Why?
|
Goals | 2 | 2016 | 716 | 0.040 |
Why?
|
Internationality | 1 | 2005 | 1008 | 0.040 |
Why?
|
Drug Utilization | 2 | 2007 | 1191 | 0.040 |
Why?
|
Computer Simulation | 2 | 2012 | 6277 | 0.040 |
Why?
|
Viruses | 1 | 2023 | 373 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2000 | 426 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 245 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 3236 | 0.040 |
Why?
|
Social Sciences | 1 | 1998 | 40 | 0.040 |
Why?
|
Urologic Surgical Procedures | 1 | 2000 | 299 | 0.040 |
Why?
|
Health Priorities | 1 | 2000 | 380 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2529 | 0.040 |
Why?
|
Malaria Vaccines | 1 | 2018 | 164 | 0.040 |
Why?
|
Ethiopia | 1 | 2019 | 482 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4266 | 0.040 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 149 | 0.030 |
Why?
|
Program Development | 2 | 2014 | 1298 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 2 | 2013 | 2596 | 0.030 |
Why?
|
Internal-External Control | 1 | 1978 | 350 | 0.030 |
Why?
|
Mass Screening | 1 | 2012 | 5451 | 0.030 |
Why?
|
Neisseria gonorrhoeae | 1 | 2018 | 249 | 0.030 |
Why?
|
Focus Groups | 2 | 2014 | 1453 | 0.030 |
Why?
|
Illegitimacy | 1 | 1995 | 4 | 0.030 |
Why?
|
Social Problems | 1 | 1995 | 108 | 0.030 |
Why?
|
Cost Sharing | 1 | 2018 | 409 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 888 | 0.030 |
Why?
|
Social Change | 1 | 1995 | 153 | 0.030 |
Why?
|
Indonesia | 1 | 2015 | 131 | 0.030 |
Why?
|
Health | 1 | 1998 | 399 | 0.030 |
Why?
|
Information Dissemination | 1 | 2023 | 1137 | 0.030 |
Why?
|
Filtration | 1 | 2014 | 228 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22385 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2017 | 740 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 1999 | 562 | 0.030 |
Why?
|
Zambia | 1 | 2013 | 273 | 0.030 |
Why?
|
Canada | 2 | 1995 | 2139 | 0.030 |
Why?
|
Transients and Migrants | 1 | 1995 | 170 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2268 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 2029 | 0.030 |
Why?
|
Incidence | 3 | 2012 | 21544 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2017 | 998 | 0.030 |
Why?
|
History, 20th Century | 1 | 2000 | 2771 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26375 | 0.020 |
Why?
|
Drug Costs | 1 | 2000 | 1196 | 0.020 |
Why?
|
Dwarfism | 2 | 1979 | 137 | 0.020 |
Why?
|
Isoxazoles | 1 | 1993 | 233 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2014 | 283 | 0.020 |
Why?
|
Violence | 1 | 1998 | 938 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54920 | 0.020 |
Why?
|
Sarcopenia | 1 | 2017 | 376 | 0.020 |
Why?
|
Parents | 2 | 2022 | 3596 | 0.020 |
Why?
|
Environment | 1 | 1998 | 1124 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1962 | 0.020 |
Why?
|
Health Planning | 1 | 2012 | 232 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1337 | 0.020 |
Why?
|
Urban Health | 1 | 2013 | 535 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10377 | 0.020 |
Why?
|
Schools | 1 | 2019 | 1496 | 0.020 |
Why?
|
Civil Rights | 1 | 1991 | 131 | 0.020 |
Why?
|
Self Report | 1 | 2022 | 3766 | 0.020 |
Why?
|
Eligibility Determination | 1 | 2013 | 421 | 0.020 |
Why?
|
Education | 1 | 1993 | 535 | 0.020 |
Why?
|
Logistic Models | 1 | 2024 | 13323 | 0.020 |
Why?
|
Health Promotion | 2 | 2014 | 2209 | 0.020 |
Why?
|
Jordan | 1 | 2009 | 73 | 0.020 |
Why?
|
Federal Government | 1 | 1991 | 266 | 0.020 |
Why?
|
Hemoglobins | 1 | 2015 | 1532 | 0.020 |
Why?
|
Survival Analysis | 2 | 2015 | 10117 | 0.020 |
Why?
|
Industry | 1 | 1991 | 365 | 0.020 |
Why?
|
Animals | 2 | 2019 | 169337 | 0.020 |
Why?
|
Community Health Services | 1 | 2014 | 659 | 0.020 |
Why?
|
Body Weight | 1 | 1979 | 4629 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2018 | 2006 | 0.020 |
Why?
|
Piperidines | 2 | 1993 | 1659 | 0.020 |
Why?
|
Sexual Behavior | 1 | 1998 | 2200 | 0.020 |
Why?
|
Decision Making | 2 | 2016 | 3953 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6430 | 0.020 |
Why?
|
Mathematics | 2 | 1979 | 704 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3912 | 0.020 |
Why?
|
Health Education | 1 | 2014 | 1057 | 0.020 |
Why?
|
Disease | 1 | 1992 | 673 | 0.020 |
Why?
|
Reproductive History | 2 | 1993 | 210 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5916 | 0.020 |
Why?
|
Indoles | 1 | 1974 | 1825 | 0.020 |
Why?
|
Weight Gain | 1 | 2016 | 2356 | 0.020 |
Why?
|
Angiomatosis | 1 | 1966 | 46 | 0.020 |
Why?
|
Photosensitivity Disorders | 1 | 1966 | 79 | 0.020 |
Why?
|
Population Surveillance | 2 | 2009 | 2598 | 0.020 |
Why?
|
Personnel Selection | 1 | 2007 | 201 | 0.020 |
Why?
|
Sincalide | 1 | 1985 | 15 | 0.020 |
Why?
|
Career Mobility | 1 | 2007 | 262 | 0.020 |
Why?
|
Life Style | 1 | 2017 | 3929 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21162 | 0.020 |
Why?
|
Survival Rate | 1 | 1999 | 12870 | 0.010 |
Why?
|
Child Welfare | 1 | 2008 | 523 | 0.010 |
Why?
|
Infection Control | 1 | 2011 | 985 | 0.010 |
Why?
|
Neurosecretory Systems | 1 | 1985 | 223 | 0.010 |
Why?
|
Anxiety | 2 | 2014 | 4677 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 941 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3707 | 0.010 |
Why?
|
Antipsychotic Agents | 2 | 1993 | 3080 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8051 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1998 | 4429 | 0.010 |
Why?
|
Parity | 1 | 1984 | 938 | 0.010 |
Why?
|
Refugees | 1 | 2009 | 612 | 0.010 |
Why?
|
Finland | 1 | 1982 | 609 | 0.010 |
Why?
|
Schizophrenia | 2 | 1993 | 6987 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5878 | 0.010 |
Why?
|
Italy | 1 | 1982 | 854 | 0.010 |
Why?
|
Family Relations | 1 | 1982 | 318 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1998 | 20224 | 0.010 |
Why?
|
Leukemia | 2 | 1979 | 1526 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9371 | 0.010 |
Why?
|
Length of Stay | 1 | 1993 | 6519 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1993 | 12092 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2014 | 4339 | 0.010 |
Why?
|
Telangiectasis | 1 | 1979 | 78 | 0.010 |
Why?
|
Facial Dermatoses | 1 | 1979 | 87 | 0.010 |
Why?
|
Verbal Behavior | 1 | 1978 | 336 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 30022 | 0.010 |
Why?
|
Time Factors | 3 | 1984 | 40272 | 0.010 |
Why?
|
Insurance, Health | 1 | 1988 | 2518 | 0.010 |
Why?
|
Europe | 1 | 1982 | 3439 | 0.010 |
Why?
|
Depression | 1 | 2014 | 8241 | 0.010 |
Why?
|
Social Welfare | 1 | 1995 | 87 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36849 | 0.010 |
Why?
|
Perception | 1 | 1978 | 1205 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1979 | 1424 | 0.010 |
Why?
|
Financial Management | 1 | 1993 | 161 | 0.010 |
Why?
|
Proteinuria | 1 | 1974 | 613 | 0.010 |
Why?
|
Risperidone | 1 | 1993 | 383 | 0.010 |
Why?
|
Probability | 1 | 1995 | 2482 | 0.010 |
Why?
|
Benzamides | 1 | 1974 | 1380 | 0.000 |
Why?
|
Jews | 1 | 1966 | 358 | 0.000 |
Why?
|
Receptors, Dopamine | 1 | 1985 | 296 | 0.000 |
Why?
|
Chromosome Disorders | 1 | 1966 | 499 | 0.000 |
Why?
|
Registries | 1 | 1979 | 8379 | 0.000 |
Why?
|
Heart Rate | 1 | 1974 | 4218 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 1995 | 12558 | 0.000 |
Why?
|
Chromosome Aberrations | 1 | 1966 | 1780 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1985 | 6034 | 0.000 |
Why?
|
Syndrome | 1 | 1979 | 3275 | 0.000 |
Why?
|
Lymphoma | 1 | 1979 | 1907 | 0.000 |
Why?
|